IL22 and lung carcinoma: IL-22 expression was consistently overexpressed in recurrent NSCLC tissue and serum, and promoted cellular proliferation and migration of tumor cells [16]; however, this elevation did not reveal correlation with prognosis of lung cancer patients [17].